Association between the functional polymorphism C-159T in the CD14 promoter gene and nasal polyposis: Potential role in asthma

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 6, 2012, Pages 406-411

  Yazdani, N ^a   Amoli, M M ^b   Naraghi, M ^a   Mersaghian, A ^a   Firouzi, F ^a   Sayyahpour, F ^b   Mokhtari, Zahra ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Allergy; Asthma; CD14 polymorphism; Nasal polyps

Indexed keywords

GENOMIC DNA; IMMUNOGLOBULIN E;

ADULT; ALLELE; ARTICLE; ASTHMA; CD14 GENE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; PATHOGENESIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR;

ADULT; ANTIGENS, CD14; ASTHMA; CHROMOSOMES, HUMAN, PAIR 5; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; IRAN; MALE; MIDDLE AGED; MUTATION; NASAL POLYPS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC;

EID: 84868012908     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mygind N, Dahl R, Bachert C. Nasal polyposis, eosinophil dominated infl ammation, and allergy. Thorax. 2000;55(Suppl 2):S79.
2. Wang DU. Signifi cance of susceptible gene expression profi le in nasal polyposis. Clin Exp Otorhinolaryngol. 2008;1(4):177-83.
3. Couto LGF, Fernades AM, Brandão DF, Santi Neto D, Valera FCP, Anselmo-Lima WT. Histological aspects of rhinosinusal polyps. Braz J Otorhinolaryngol. 2008;4(7):207-12.
4. Klossek JM, Neukirch F, Pribil C, Jankowski R, Serrano E, Chanal I, El Hasnaoui A. Prevalence of nasal polyposis in France: a cross sectional, case-control study. Allergy. 2005;60(2):233-7.
5. Önerci TM, Berrylin FJ. Nasal Polyps in Cystic Fibrosis. In: Schlosser RJ, Sheahan PO. Harvey RJ. Nasal Polyposis. Springer-Verlag Berlin Heidelberg 2010. p. 145-6.
6. von Aulock S, Rupp J, Gueinzius K, Maass M, Hermann C. Critical investigation of the CD14 promoter polymorphism: lack of a role for in vitro cytokine response and membrane CD14 expression. Clin Diagn Lab Immunol. 2005;12(10):1254-6.
7. Amoli MM, Hand S, Hajeer AH, Jones KP, Rolf S, Sting C, Davies BH, Ollier WE. Polymorphism in the STAT6 gene encodes risk for nut allergy. Genes Immun. 2002;3(4):220-4.
8. Blumenthal M. The role of genetics in the development of asthma and atopy. Curr Opin Allergy Clin Immunol. 2005;5(2):141.
9. Saçkesen C, Karaaslan C, Keskin O, Tokol N, Tahan F, Civelek E, Soyer OU, Adalioglu G, Tuncer A, Birben E, Oner C, Kalayci O. The effect of polymorphisms at the CD14 promoter and the TLR4 gene on asthma phenotypes in Turkish children with asthma. Allergy. 2005;60(12):1485-92.
10. Leung TF, Tang NL, Sung YM, Li AM, Wong GW, Chan IH, Lam CW. The C-159T polymorphism in the CD14 promoter is associated with serum total IgE concentration in atopic Chinese children. Pediatr Allergy Immunol. 2003;14(4):255-60.
11. Zhang G, Khoo SK, Laatikainen T, Pekkarinen P, Vartiainen E, von Hertzen L, Hayden CM, Goldblatt J, Mäkelä M, Haahtela T, Le Souëf PN. Opposite gene by environment interactions in Karelia for CD14 and CC16 single nucleotide polymorphisms and allergy. Allergy. 2009;64(9):1333-41.
12. Gao P. Serum total IgE levels and CD14 on chromosome 5q31. Clin Genet. 1999;56(2):164-5.
13. Zhang Y, Tian C, Zhang J, Li X, Wan H, He C, Guo L, Meilang Q, Peng C, Duo L, Huang J, Fan H. The-159C/T polymorphism in the CD14 gene and the risk of asthma: a meta-analysis. Immunogenetics. 2011;63(1):23-32.
14. Verhasselt V, Buelens C, Willems F, et al. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. J Immunol. 1997;158:2919-25.
15. Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science. 1994;264(5162):1152-6.
16. Han D, She W, Zhang L. Association of the CD14 gene polymorphism C-159T with allergic rhinitis. Am J Rhinol Allergy. 2010;24(1):e1-3.
17. Hamajima Y, Fujieda S, Sunaga H, Yamada T, Moribe K, Watanabe N, Murakami S. Expression of Syk is associated with nasal polyp in patients with allergic rhinitis. Auris Nasus Larynx. 2007;34(1):49-56.
18. Sharma M, Batra J, Mabalirajan U, Goswami S, Ganguly D, Lahkar B, Bhatia NK, Kumar A, Ghosh B. Suggestive evidence of association of C-159T functional polymorphism of the CD14 gene with atopic asthma in northern and northwestern Indian populations. Immunogenetics. 2004;56(7)544-7.
19. Woo JG, Assa'ad A, Heizer AB, Bernstein JA, Khurana Hershey GK. The-159 C-->T polymorphism of CD14 is associated with nonatopic asthma and food allergy. J Allergy Clin Immunol. 2003;112(2):438-44.
20. Wang JY, Wang LM, Lin CGJ, Chang ACW and Wu LSH. Association study using combination analysis of SNP and STRP markers: CD14 promoter polymorphism and IgE level in Taiwanese asthma children. J Hum Genet. 2005;50(1)36-41.
21. Sengler C, Haider A, Sommerfeld C, Lau S, Baldini M, Martinez F, Wahn U, Nickel R. German Multicenter Allergy Study Group: Evaluation of the CD14 C 159 T polymorphism in the German Multicenter Allergy Study cohort. Clin Exp Allergy. 2003;33(2):166-9.
22. Baldini M, Lohman IC, Halonen M, Erickson RP, Holt PG, Martinez FD. A Polymorphism* in the 5' fl anking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol. 1999;20(9)976-83.
23. Koppelman GH, Reijmerink NE, Colin Stine O, Howard TD, Whittaker PA, Meyers DA, Postma DS, Bleecker ER. Association of a promoter polymorphism of the CD14 gene and atopy. Am J Respir Crit Care Med. 2001;63(4):965.
24. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1(5):398-401.
25. Tobias P, Ulevitch R. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation. Immunobiology. 1993;187(3-5):227.
26. Triantafi lou M, Triantafi lou K. Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster. Trends Immunol. 2002;3(6):301-4.
27. Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, Ronchi AE, Rocchetti M, Mingozzi F, Foti M, Chirico G, Costa B, Zaza A, Ricciardi-Castagnoli P, Granucci F. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature. 2009;460(7252):264-8.
28. Hoffjan S, D Nicolae, Ober C. Association studies for asthma and atopic diseases: a comprehensive review of the literature. Respir Res. 2003;4(1):14.
29. Heinzmann A, Dietrich H, Jerkic SP, Kurz T, Deichmann KA. Promoter polymorphisms of the CD14 gene are not associated with bronchial asthma in Caucasian children. Eur J Immunogenet. 2003;30(5):345-8.
30. Kedda MA, Lose F, Duffy D, Bell E, Thompson PJ, Upham J. The CD14 C-159T polymorphism is not associated with asthma or asthma severity in an Australian adult population. Thorax. 2005;60(3):211.
31. Zhao L, Bracken MB. Association of CD14-260 (-159) C>T and asthma: a systematic review and meta-analysis. BMC Med Genet. 2011;12:93.
32. Kowal K, Bodzenta-Lukaszyk A, Pampuch A, Szmitkowski M, Zukowski S, Donati MB, Iacoviello L. Analysis of-675 4G/5G SERPINE1 and C-159T CD14 polymorphisms in house dust mite-allergic asthma patients. J Investig Allergol Clin Immunol. 2008;18(4):284-92.
33. van Drunen CM, Reinartz S, Wigman J, Fokkens WJ. Infl ammation in chronic rhinosinusitis and nasal polyposis. Immunol Allergy Clin North Am. 2009;29(4):621-9.